At an event for pharmaceutical executives, biotech founders, and researchers on Tuesday, Anthropic announced Claude Science, ...

Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to ...

Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...

Claude Science launches as big tech companies increasingly eye expansion in the wider healthcare space.

Anthropic is launching an internal drug discovery program with a focus on neglected diseases that traditional pharmaceutical companies would not consider commercially attractive, CNBC reported June 30 ...

Drug-induced liver damage is ​a major cause of trial failures, and current methods do not reliably predict human risk. The U.S. Food and Drug Administration said the tool could potentially help ...

A German company that provides products and services that accelerate drug development and manufacturing is set to acquire the ...

The proposed federal budget would see drastic cuts made to most of the agencies that fund science. The sheer magnitude of the cuts—including a 40 percent slashing of money going to the National ...

This Brush Up is sponsored by MilliporeSigma. Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug ...

(a) Success rate, timeline, and cost (in billions) of traditional drug development versus RNA drug development, along with a description of the evolutionary progress of the latter. (b) The future ...